Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T38087 | Target Info | |||
Target Name | Tankyrase-2 (TNKS-2) | ||||
Synonyms | Tankyrase-related protein; Tankyrase-like protein; Tankyrase II; TRF1-interacting ankyrin-related ADP-ribose polymerase 2; TNKL; TANK2; Protein poly-ADP-ribosyltransferase tankyrase-2; Poly [ADP-ribose] polymerase tankyrase-2; Poly [ADP-ribose] polymerase 5B; PARP5B; ARTD6; ADP-ribosyltransferase diphtheria toxin-like 6 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | TNKS2 | ||||
Biochemical Class | Glycosyltransferases | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 3-aminobenzamide | Ligand Info | |||
Canonical SMILES | C1=CC(=CC(=C1)N)C(=O)N | ||||
InChI | 1S/C7H8N2O/c8-6-3-1-2-5(4-6)7(9)10/h1-4H,8H2,(H2,9,10) | ||||
InChIKey | GSCPDZHWVNUUFI-UHFFFAOYSA-N | ||||
PubChem Compound ID | 1645 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 4PML Crystal Structure of human Tankyrase 2 in complex with 3-amino-benzamide. | ||||||
Method | X-ray diffraction | Resolution | 1.87 Å | Mutation | No | [1] |
PDB Sequence |
KEFQSVEEEM
972 QSTVREHRDG982 GHAGGIFNRY992 NILKIQKVCN1002 KKLWERYTHR1012 RKEVSEENHN 1022 HANERMLFHG1032 SPFVNAIIHK1042 GFDERHAYIG1052 GMFGAGIYFA1062 ENSSKSNQYV 1072 YGIGGGTGCP1082 VHKDRSCYIC1092 HRQLLFCRVT1102 LGKSFLQFSA1112 MKMAHSPPGH 1122 HSVTGRPSVG1133 LALAEYVIYR1143 GEQAYPEYLI1153 TYQIMRPE
|
|||||
|
||||||
PDB ID: 4TKF Crystal Structure of human Tankyrase 2 in complex with IWR-1. | ||||||
Method | X-ray diffraction | Resolution | 2.60 Å | Mutation | No | [1] |
PDB Sequence |
DKEFQSVEEE
971 MQSTVREHRD981 GGHAGGIFNR991 YNILKIQKVC1001 NKKLWERYTH1011 RRKEVSEENH 1021 NHANERMLFH1031 GSPFVNAIIH1041 KGFDERHAYI1051 GGMFGAGIYF1061 AENSSKSNQY 1071 VYGIGGGTGC1081 PVHKDRSCYI1091 CHRQLLFCRV1101 TLGKSFLQFS1111 AMKMAHSPPG 1121 HHSVTGRPSV1131 NGLALAEYVI1141 YRGEQAYPEY1151 LITYQIMRP
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2. Acta Crystallogr D Biol Crystallogr. 2014 Oct;70(Pt 10):2740-53. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.